title: 2012-2013 influenza update: hitting a rapidly moving target.
abstract: From the deadly 2009 influenza A H1N1 pandemic to the looming threat of bird flu H5N1, the recent outbreak of swine flu H3N2v at agriculture fairs, and the emergence of drug-resistant H1N1, we are constantly challenged by influenza viruses. Vaccination remains the main strategy for prevention. With the knowledge gained from past pandemics, an adequate vaccine supply, and an updated preventive strategy, we are in a better position to face the challenge.
authors.affiliation: Department of Internal Medicine, Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. jinx@ccf.org
authors.forename: Xian Wen
authors.initials: XW
authors.lastname: Jin
authors.forename: Sherif Beniameen
authors.initials: SB
authors.lastname: Mossad
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D024921:Drug Resistance, Multiple, Viral; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000592:standards; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control / Q000821:virology; D009439:Neuraminidase / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D053139:Oseltamivir / Q000627:therapeutic use; D058873:Pandemics / Q000517:prevention & control / Q000706:statistics & numerical data; D017410:Practice Guidelines as Topic
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir; D009439:Neuraminidase